Hiroshi Kikuchi started a consultant for DDS research at the pharmaceutical companies since February 2021, and because of business expansion ‘DDS Strategy Firm LLC’ (President: Hiroshi Kikuchi) was founded on July 1st, 2024.
Hiroshi Kikuchi has worked for the pharmaceutical companies and a venture company for 47 years, and he would like to hand the knowledge and know-how on to the next generation. He would like to create DDS medicines of Japanese origin and contribute to medical treatment of the world. Hiroshi Kikuchi thinks it becomes his gratitude to a lot of people who have taken care of him cordially for a long time.
DDS Strategy Firm LLC will become a consultant for DDS research which is performed at the pharmaceutical companies, the venture companies and the universities. Its main research area is liposomes and lipid nanoparticles (LNPs). Recently, LNPs have gained much prominence, because some mRNA-LNP vaccines have been launched out in the world, which can finally save the life of many people. Hiroshi Kikuchi’s review article is as follows.
Hiroshi Kikuchi: Study and their future perspective of lipid nanoparticles.
The company will also accept the request of the lecture at companies/universities/academic societies. In such case, please use “Contact Form”.
Hiroshi Kikuchi, Ph.D.
President, DDS Strategy Firm LLC
（E-mail: hiroshi.kikuchi@dds-firm.com）
Asian Federation for Pharmaceutical Sciences 2013 @Jeju, Republic of Korea, November 21, 2013